CD19-targeted immunotherapy T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19-targeted immunotherapy T cells, covering 2016-02-03 to 2016-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess CD19-targeted Immunotherapy T Cells in Patients With Relapsed or Refractory CD19+ B Cell Leukemia [Phase 1, Phase 2]